Canada
· Delayed Price · Currency is CAD Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 469.47 million. The enterprise value is 1.02 billion.
| Market Cap | 469.47M |
| Enterprise Value | 1.02B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 355.66 million shares outstanding. The number of shares has increased by 2.67% in one year.
| Current Share Class | 338.23M |
| Shares Outstanding | 355.66M |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | +1.16% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | 15.09% |
| Float | 332.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.51 |
| PB Ratio | 0.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.83 |
| P/OCF Ratio | 2.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.33, with an EV/FCF ratio of 8.28.
| EV / Earnings | -16.31 |
| EV / Sales | 1.10 |
| EV / EBITDA | 4.33 |
| EV / EBIT | 8.33 |
| EV / FCF | 8.28 |
Financial Position
The company has a current ratio of 3.10, with a Debt / Equity ratio of 1.75.
| Current Ratio | 3.10 |
| Quick Ratio | 1.84 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | 3.66 |
| Debt / FCF | 7.02 |
| Interest Coverage | 1.51 |
Financial Efficiency
Return on equity (ROE) is -9.89% and return on invested capital (ROIC) is 5.46%.
| Return on Equity (ROE) | -9.89% |
| Return on Assets (ROA) | 4.13% |
| Return on Invested Capital (ROIC) | 5.46% |
| Return on Capital Employed (ROCE) | 7.17% |
| Revenue Per Employee | 318,554 |
| Profits Per Employee | -21,483 |
| Employee Count | 2,900 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 3.75 |
Taxes
In the past 12 months, Cresco Labs has paid 71.72 million in taxes.
| Income Tax | 71.72M |
| Effective Tax Rate | 324.55% |
Stock Price Statistics
The stock price has decreased by -50.19% in the last 52 weeks. The beta is 1.40, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -50.19% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 65.28 |
| Average Volume (20 Days) | 451,157 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 923.81 million and -62.30 million in losses. Loss per share was -0.18.
| Revenue | 923.81M |
| Gross Profit | 452.29M |
| Operating Income | 121.93M |
| Pretax Income | 22.10M |
| Net Income | -62.30M |
| EBITDA | 195.49M |
| EBIT | 121.93M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 199.95 million in cash and 860.47 million in debt, giving a net cash position of -660.51 million or -1.86 per share.
| Cash & Cash Equivalents | 199.95M |
| Total Debt | 860.47M |
| Net Cash | -660.51M |
| Net Cash Per Share | -1.86 |
| Equity (Book Value) | 492.23M |
| Book Value Per Share | 1.70 |
| Working Capital | 290.89M |
Cash Flow
In the last 12 months, operating cash flow was 161.13 million and capital expenditures -38.49 million, giving a free cash flow of 122.65 million.
| Operating Cash Flow | 161.13M |
| Capital Expenditures | -38.49M |
| Free Cash Flow | 122.65M |
| FCF Per Share | 0.34 |
Margins
Gross margin is 48.96%, with operating and profit margins of 13.20% and -6.74%.
| Gross Margin | 48.96% |
| Operating Margin | 13.20% |
| Pretax Margin | 2.39% |
| Profit Margin | -6.74% |
| EBITDA Margin | 21.16% |
| EBIT Margin | 13.20% |
| FCF Margin | 13.28% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | n/a |
| Earnings Yield | -13.27% |
| FCF Yield | 26.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.3 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.3 |
| Piotroski F-Score | 5 |